Factors affecting vitiligo response to treatment: do MiRNA 196a2C/T gene polymorphism and serum tyrosinase levels have any role?

References

• Ezzedine K, Eleftheriadou V. Vitiligo and quality of life: the dark face of whiteness. Br J Dermatol. 2018; 178(1):28–29.
   PubMed Web of Science ®Google Scholar
• Agarwal K, Podder I, Kassir M, et al. Therapeutic options in vitiligo with special emphasis on immunomodulators: A comprehensive update with review of literature. Dermatol Ther. 2020;33(2):e13215.
   Web of Science ®Google Scholar
• Abreu AC, Duarte GG, Miranda JY, et al. Immunological parameters associated with vitiligo treatments: a literature review based on clinical studies. Autoimmune Dis. 2015;2015:196537.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102–114.
   PubMed Web of Science ®Google Scholar
• Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev. 2011;91(3):827–887.
   PubMed Web of Science ®Google Scholar
• Osman A. MicroRNAs in health and disease–basic science and clinical applications. Clin Lab. 2012;58(5-6):393–402.
   PubMed Web of Science ®Google Scholar
• Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14(8):535–548.
   PubMed Web of Science ®Google Scholar
• Dynoodt P, Mestdagh P, Van Peer G, et al. Identification of miR-145 as a key regulator of the pigmentary process. J Invest Dermatol. 2013;133(1):201–209.
   PubMed Web of Science ®Google Scholar
• Parihar AS, Tembhre MK, Sharma VK, et al. Effect of narrowband ultraviolet B treatment on micro RNA expression in active non-segmental generalized vitiligo. Br J Dermatol. 2020;183(1):167–169.
   PubMed Web of Science ®Google Scholar
• Jimbow K, Chen H, Park JS, et al. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol. 2001;144(1):55–65.
   PubMed Web of Science ®Google Scholar
• Huang Y, Yi X, Jian Z, et al. A single-nucleotide polymorphism of miR-196a-2 and vitiligo: an association study and functional analysis in a Han Chinese population. Pigment Cell Melanoma Res. 2013;26(3):338–347.
   PubMed Web of Science ®Google Scholar
• Hamzavi I, Jain H, McLean D, et al. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140(6):677–683.
   PubMedGoogle Scholar
• Totonchy MB, Chiu MW. UV-based therapy. Dermatol Clin. 2014; 32(3):399–414.
   PubMed Web of Science ®Google Scholar
• Kawakami T, Hashimoto T. Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol Res Pract. 2011;2011:750342.
   PubMedGoogle Scholar
• Cui T, Yi X, Zhang W, et al. miR-196a-2 rs11614913 polymorphism is associated with vitiligo by affecting heterodimeric molecular complexes of Tyr and Tyrp1. Arch Dermatol Res. 2015;307(8):683–692.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Hearing VJ. Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo. J Cell Sci. 2007; 120(Pt 24):4261–4268.
   PubMed Web of Science ®Google Scholar
• Tada M, Kohno M, Kasai S, et al. Generation mechanism of radical species by tyrosine-tyrosinase reaction. J Clin Biochem Nutr. 2010;47(2):162–166.
   PubMed Web of Science ®Google Scholar
• Fawzy MS, Hussein MH, Abdelaziz EZ, et al. Association of MicroRNA-196a2 variant with response to short-acting β2-agonist in COPD: an Egyptian pilot study. PLoS One. 2016;11(4):e0152834.
   PubMed Web of Science ®Google Scholar
• Kandaswamy S, Akhtar N, Ravindran S, et al. Phototherapy in vitiligo: assessing the compliance, response and patient's perception about disease and treatment. Indian J Dermatol. 2013;58(4):325.
   PubMedGoogle Scholar
• Youn Lee D, Lee JH. White hairs in segmental vitiligo are related to poor response to phototherapy: demonstration with portable digital microscopy. J Dermatol. 2010;37(5):500–501.
   PubMed Web of Science ®Google Scholar
• Rubin D, Desai N, Graham-Pole J, et al. Spirituality in well and ill adolescents and their parents: the use of two assessment scales. Pediatr Nur. 2009; 35(1):32–42.
   Google Scholar
• Harvey IS, Silverman M. The role of spirituality in the self-management of chronic illness among older african and whites. J Cross Cult Gerontol. 2007;22(2):205–220.
   PubMedGoogle Scholar
• Koblenzer CS. The emotional impact of chronic and disabling skin disease: a psychoanalytic perspective. Dermatol Clin. 2005;23(4):619–627.
   PubMed Web of Science ®Google Scholar
• Nogueira LS, Zancanaro PC, Azambuja RD. [Vitiligo and emotions]. An Bras Dermatol. 2009;84(1):41–45.
   PubMed Web of Science ®Google Scholar
• Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol. 2001;44(6):999–1003.
   PubMed Web of Science ®Google Scholar
• Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30(4):332–336.
   PubMed Web of Science ®Google Scholar
• Brazzelli V, Antoninetti M, Palazzini S, et al. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J Eur Acad Dermatol Venereol. 2007;21(10):1369–1374.
   PubMed Web of Science ®Google Scholar
• Parsad D, Bhatnagar A, De D. Narrowband ultraviolet B for the treatment of vitiligo. Expert Rev Dermatol. 2010;5(4):445–459.
   Google Scholar
• Hallaji Z, Ghiasi M, Eisazadeh A, et al. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed. 2012;28(3):115–119.
   PubMed Web of Science ®Google Scholar
• Rowe MM, Allen RG. Spirituality as a mean of coping with chronic illness. Am. J. Health Studies. 2004;19(1):62–67.
   Google Scholar